- Home
- MNPR vs LCNB Comparison
MNPR vs LCNB Comparison
Compare MNPR & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- LCNB
- Stock Information
- Founded
- MNPR 2014
- LCNB 1877
- Country
- MNPR United States
- LCNB United States
- Employees
- MNPR N/A
- LCNB N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- LCNB Major Banks
- Sector
- MNPR Health Care
- LCNB Finance
- Exchange
- MNPR Nasdaq
- LCNB Nasdaq
- Market Cap
- MNPR 248.8M
- LCNB 205.5M
- IPO Year
- MNPR 2019
- LCNB N/A
- Fundamental
- Price
- MNPR $66.64
- LCNB $15.85
- Analyst Decision
- MNPR Strong Buy
- LCNB
- Analyst Count
- MNPR 11
- LCNB 0
- Target Price
- MNPR $68.60
- LCNB N/A
- AVG Volume (30 Days)
- MNPR 44.1K
- LCNB 17.1K
- Earning Date
- MNPR 11-07-2025
- LCNB 10-20-2025
- Dividend Yield
- MNPR N/A
- LCNB 5.49%
- EPS Growth
- MNPR N/A
- LCNB 186.06
- EPS
- MNPR N/A
- LCNB 1.49
- Revenue
- MNPR N/A
- LCNB $86,864,000.00
- Revenue This Year
- MNPR N/A
- LCNB $0.86
- Revenue Next Year
- MNPR N/A
- LCNB $5.93
- P/E Ratio
- MNPR N/A
- LCNB $10.75
- Revenue Growth
- MNPR N/A
- LCNB 22.73
- 52 Week Low
- MNPR $3.90
- LCNB $13.34
- 52 Week High
- MNPR $68.18
- LCNB $17.92
- Technical
- Relative Strength Index (RSI)
- MNPR 80.24
- LCNB 52.62
- Support Level
- MNPR $42.51
- LCNB $15.73
- Resistance Level
- MNPR $45.78
- LCNB $16.34
- Average True Range (ATR)
- MNPR 4.36
- LCNB 0.36
- MACD
- MNPR 2.91
- LCNB -0.03
- Stochastic Oscillator
- MNPR 95.65
- LCNB 46.73
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.